The company is specifically seeking to dominate a target market it estimates at $20 billion for its lead candidate, PT00114. This is a strong indication that Protagenic Therapeutics could be pivotal in mental health therapeutics in the future. Recent studies by the Cleveland Clinic indicate that stress is on the rise, likely confirming what many already suspected - the pandemic has lead to higher stress. The company engages in the development of therapeutics for stress-related neuropsychiatric and mood disorders. That is where Protagenic Therapeutics focuses its efforts. But recently, there has been an increasing focus on the mind, stress and mood disorders, which wasn’t really the case a few years ago. Traditionally, biotech companies seek to commercialize therapeutics which alleviate problems related to physical health. The list below will include those which have the potential for 10X gains. Whether that happens or not, penny stocks already have the power to rise quickly. If that is the case, such demand could raise prices quickly.

My guess is that penny stocks could see an upsurge in popularity in the near future: Now that cryptomania has cooled, investors with higher risk tolerance may pivot into penny stocks. Yes, that is of course balanced by substantial risk, but the fact remains that penny stocks will always be alluring. That volatility means that investors can potentially receive very quick gains. But they remain popular, as they are inexpensive and often volatile. There remains no consensus as to the “true” definition of a penny stock.

This was the traditional definition of a penny stock, and the one you’re most likely to see. Some stick to the idea that penny stocks are those that trade below $1. There are a few definitions by which investors define penny stocks.

Best penny stocks to buy now